ESTEVE RD UK & IRELAND LTD.
Get an alert when ESTEVE RD UK & IRELAND LTD. files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-03-18
Overdue
Watchouts
Cash
£1M
-79.5% vs 2023
Net assets
£10M
+5.8% highest in 4 filed years
Employees
4
+33.3% vs 2023
Profit before tax
£750K
+185.8% highest in 4 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Confirmation statement overdue
Due 2026-03-18.
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Net assets
4-year trend · vs Consumer Discretionary median
Accounts
4-year trend · latest reflected 2024-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Turnover | £15,735,763 | £20,908,478 | £9,370,781 | £5,283,606 | |
| Operating profit | £505,616 | £81,294 | £268,395 | £355,961 | |
| Profit before tax | £481,916 | £134,034 | £262,302 | £749,599 | |
| Net profit | £389,522 | £108,521 | £209,481 | £562,199 | |
| Cash | £363,498 | £910,431 | £5,248,556 | £1,077,226 | |
| Total assets less current liabilities | £9,998,156 | £10,106,677 | — | — | |
| Net assets | — | — | £9,610,853 | £10,173,052 | |
| Equity | £9,998,156 | £10,106,677 | £9,610,853 | £10,173,052 | |
| Average employees | 17 | 20 | 3 | 4 | |
| Wages | £2,914,345 | £3,788,986 | £557,229 | £615,699 | |
| Directors' remuneration | £206,426 | £230,465 | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-43.6%
£9,370,781 £5,283,606
lowest in 4 filed years
-
Cash
-79.5%
£5,248,556 £1,077,226
-
Net assets
+5.8%
£9,610,853 £10,173,052
-
Employees
+33.3%
3 4
-
Operating profit
+32.6%
£268,395 £355,961
-
Profit before tax
+185.8%
£262,302 £749,599
highest in 4 filed years
-
Wages
+10.5%
£557,229 £615,699
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Operating margin | 3.2% | 0.4% | 2.9% | 6.7% | |
| Net margin | 2.5% | 0.5% | 2.2% | 10.6% | |
| Return on capital employed | 5.1% | 0.8% | — | — | |
| Current ratio | — | — | 3.51x | 11.57x | |
| Interest cover | 21.33x | 0.58x | 44.05x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation — the current trading name was adopted 2024-07-29
- ESTEVE RD UK & IRELAND LTD. 2024-07-29 → present
- HRA PHARMA UK & IRELAND LIMITED 2011-12-01 → 2024-07-29
- HRA PHARMA UK LIMITED 2009-03-04 → 2011-12-01
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Constantin
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis which assumes that the Company will continue in operational existence for at least 12 months from date of the approval and meet its liabilities as they fall due. The company remains assured of the financial support provided by Esteve Healthcare S.L., the ultimate controlling party. The directors have received confirmation that Esteve Healthcare S.L. will continue to support the company and provide it with adequate funds when necessary to enable it to meet its debts as they fall due in the foreseeable future. On this basis, the directors consider it appropriate to prepare the financial statements on a going concern basis.”
Significant events
- “The Company is a wholly owned subsidiary of Esteve Healthcare S.L (Spain), following its acquisition in June 2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 11 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HALL, Scott Douglas | Director | 2025-02-17 | Nov 1971 | British |
| TOLSTRUP, Jacob | Director | 2025-01-15 | May 1972 | Danish |
Show 11 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALLAN, David Geoffrey | Director | 2019-07-17 | 2023-01-10 |
| BREON-NORMAND, Valérie | Director | 2019-07-17 | 2023-01-10 |
| DE MELLO BARRETO, Goncalo Jose Geada | Director | 2024-07-10 | 2025-01-28 |
| FRASER, Anthony Charles | Director | 2009-03-04 | 2018-01-01 |
| HALL, Scott Douglas | Director | 2024-03-31 | 2024-07-10 |
| HOLLIES, Sonia | Director | 2022-07-01 | 2024-07-10 |
| HOLME, Richard | Director | 2016-01-18 | 2024-03-31 |
| MUNTANOLA PRAT, Jorge | Director | 2024-07-10 | 2025-01-15 |
| RIVERS, Dominic | Director | 2023-01-10 | 2024-07-10 |
| RUDD, Chris | Director | 2023-01-10 | 2024-07-10 |
| WRIGHT, David John | Director | 2019-01-01 | 2019-07-18 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Laboratoire Hra Pharma Sas | Corporate entity | Shares 75–100% | 2024-03-12 | Ceased 2024-03-12 |
| Perrigo Company Public Limited Company | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-11-25 | Ceased 2024-07-10 |
Filing timeline
Last 20 of 91 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-02-07 MA Memorandum articles
- 2025-02-07 RESOLUTIONS Resolution
- 2024-07-29 RESOLUTIONS Resolution
- 2024-07-29 CERTNM Certificate change of name company
- 2024-07-12 RESOLUTIONS Resolution
- 2024-07-12 RESOLUTIONS Resolution
- 2024-07-12 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-10-07 | AA | accounts | Accounts with accounts type full | |
| 2025-03-20 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2025-03-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-19 | AP01 | officers | Appoint person director company with name date | |
| 2025-02-10 | AA | accounts | Accounts with accounts type full | |
| 2025-02-07 | MA | incorporation | Memorandum articles | |
| 2025-02-07 | RESOLUTIONS | resolution | Resolution | |
| 2025-02-05 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-17 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-17 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-08 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-08 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-29 | RESOLUTIONS | resolution | Resolution | |
| 2024-07-29 | CERTNM | change-of-name | Certificate change of name company | |
| 2024-07-26 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2024-07-25 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2024-07-12 | RESOLUTIONS | resolution | Resolution | |
| 2024-07-12 | RESOLUTIONS | resolution | Resolution | |
| 2024-07-12 | MA | incorporation | Memorandum articles | |
| 2024-07-11 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 1
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.